Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement

Background : This study aimed to compare preliminary data on the outcomes of sutureless aortic valve replacement (SU-AVR) with those of aortic valve replacement (AVR). Methods : We conducted a retrospective study of SU-AVR in moderate- to high-risk patients from 2013 to 2016. Matching was performed...

Full description

Bibliographic Details
Main Authors: Puwadon Thitivaraporn, Sarun Chiramongkol, Dittapol Muntham, Nopporn Pornpatrtanarak, Chanapong Kittayarak, Jule Namchaisiri, Seri Singhatanadgige, Pat Ongcharit, Vichai Benjacholamas
Format: Article
Language:English
Published: Korean Society for Thoracic and Cardiovascular Surgery 2018-06-01
Series:Korean Journal of Thoracic and Cardiovascular Surgery
Subjects:
Online Access:https://doi.org/10.5090/kjtcs.2018.51.3.172
_version_ 1818684797999906816
author Puwadon Thitivaraporn
Sarun Chiramongkol
Dittapol Muntham
Nopporn Pornpatrtanarak
Chanapong Kittayarak
Jule Namchaisiri
Seri Singhatanadgige
Pat Ongcharit
Vichai Benjacholamas
author_facet Puwadon Thitivaraporn
Sarun Chiramongkol
Dittapol Muntham
Nopporn Pornpatrtanarak
Chanapong Kittayarak
Jule Namchaisiri
Seri Singhatanadgige
Pat Ongcharit
Vichai Benjacholamas
author_sort Puwadon Thitivaraporn
collection DOAJ
description Background : This study aimed to compare preliminary data on the outcomes of sutureless aortic valve replacement (SU-AVR) with those of aortic valve replacement (AVR). Methods : We conducted a retrospective study of SU-AVR in moderate- to high-risk patients from 2013 to 2016. Matching was performed at a 1:1 ratio using the Society of Thoracic Surgeons predicted risk of mortality score with sex and age. The primary outcome was 30-day mortality. The secondary outcomes were operative outcomes and complications. Results : A total of 277 patients were studied. Ten patients (50% males; median age, 81.5 years) underwent SU-AVR. Postoperative echocardiography showed impressive outcomes in the SU-AVR group. The 30-day mortality was 10% in both groups. In our study, the patients in the SU-AVR group developed postoperative thrombocytopenia. Platelet counts decreased from 225X103 /μL preoperatively to 94.5, 54.5, and 50.1X10 3/μL on postoperative days 1, 2, and 3, respectively, showing significant differences compared with the AVR group (p=0.04, p=0.16, and p=0.20, respectively). The median amount of platelet transfusion was higher in the AVR group (12.5 vs. 0 units, p=0.052). Conclusion : There was no difference in the 30-day mortality of moderate- to high-risk patients depending on whether they underwent SU-AVR or AVR. Although SU-AVR is associated with favorable cardiopulmonary bypass and cross-clamp times, it may be associated with postoperative thrombocytopenia.
first_indexed 2024-12-17T10:56:21Z
format Article
id doaj.art-3ee41699f5cb4b1fa0b1e7f59ce1bf0b
institution Directory Open Access Journal
issn 2233-601X
language English
last_indexed 2024-12-17T10:56:21Z
publishDate 2018-06-01
publisher Korean Society for Thoracic and Cardiovascular Surgery
record_format Article
series Korean Journal of Thoracic and Cardiovascular Surgery
spelling doaj.art-3ee41699f5cb4b1fa0b1e7f59ce1bf0b2022-12-21T21:51:47ZengKorean Society for Thoracic and Cardiovascular SurgeryKorean Journal of Thoracic and Cardiovascular Surgery2233-601X2018-06-0151317217910.5090/kjtcs.2018.51.3.172kjtcs.2018.51.3.172Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve ReplacementPuwadon Thitivaraporn0Sarun Chiramongkol1Dittapol Muntham2Nopporn Pornpatrtanarak3Chanapong Kittayarak4Jule Namchaisiri5Seri Singhatanadgige6Pat Ongcharit7Vichai Benjacholamas8Cardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalSection of Mathematic, Faculty of Science and Technology, Rajamangala University of Technology SuvarnabhumiCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalCardiovascular and Thoracic Surgery Unit, King Chulalongkorn Memorial HospitalBackground : This study aimed to compare preliminary data on the outcomes of sutureless aortic valve replacement (SU-AVR) with those of aortic valve replacement (AVR). Methods : We conducted a retrospective study of SU-AVR in moderate- to high-risk patients from 2013 to 2016. Matching was performed at a 1:1 ratio using the Society of Thoracic Surgeons predicted risk of mortality score with sex and age. The primary outcome was 30-day mortality. The secondary outcomes were operative outcomes and complications. Results : A total of 277 patients were studied. Ten patients (50% males; median age, 81.5 years) underwent SU-AVR. Postoperative echocardiography showed impressive outcomes in the SU-AVR group. The 30-day mortality was 10% in both groups. In our study, the patients in the SU-AVR group developed postoperative thrombocytopenia. Platelet counts decreased from 225X103 /μL preoperatively to 94.5, 54.5, and 50.1X10 3/μL on postoperative days 1, 2, and 3, respectively, showing significant differences compared with the AVR group (p=0.04, p=0.16, and p=0.20, respectively). The median amount of platelet transfusion was higher in the AVR group (12.5 vs. 0 units, p=0.052). Conclusion : There was no difference in the 30-day mortality of moderate- to high-risk patients depending on whether they underwent SU-AVR or AVR. Although SU-AVR is associated with favorable cardiopulmonary bypass and cross-clamp times, it may be associated with postoperative thrombocytopenia.https://doi.org/10.5090/kjtcs.2018.51.3.172Sutureless valve replacementModerate to high risk patientPostoperative thrombocytopeniaAortic valve replacement
spellingShingle Puwadon Thitivaraporn
Sarun Chiramongkol
Dittapol Muntham
Nopporn Pornpatrtanarak
Chanapong Kittayarak
Jule Namchaisiri
Seri Singhatanadgige
Pat Ongcharit
Vichai Benjacholamas
Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
Korean Journal of Thoracic and Cardiovascular Surgery
Sutureless valve replacement
Moderate to high risk patient
Postoperative thrombocytopenia
Aortic valve replacement
title Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
title_full Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
title_fullStr Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
title_full_unstemmed Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
title_short Thrombocytopenia in Moderate- to High-Risk Sutureless Aortic Valve Replacement
title_sort thrombocytopenia in moderate to high risk sutureless aortic valve replacement
topic Sutureless valve replacement
Moderate to high risk patient
Postoperative thrombocytopenia
Aortic valve replacement
url https://doi.org/10.5090/kjtcs.2018.51.3.172
work_keys_str_mv AT puwadonthitivaraporn thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT sarunchiramongkol thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT dittapolmuntham thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT noppornpornpatrtanarak thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT chanapongkittayarak thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT julenamchaisiri thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT serisinghatanadgige thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT patongcharit thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement
AT vichaibenjacholamas thrombocytopeniainmoderatetohighrisksuturelessaorticvalvereplacement